EGFR and neoplasm: The information that can be extracted from ctDNA could be used to confirm real-time tumor genetic information and to optimize the strategy of chemotherapy regimens, such as anti-EGFR mAb rechallenge and anti-EGFR mAb for NeoRAS WT mCRC.